Patient enrolment and retention can be quite a challenge when dealing with homebound patients, an orphan indication, or a dispersed patient population. Clinigen has designed a Direct-to-Patient programme, which provides a highly customizable solution per patient and per protocol. Clinigen is ahead of the others in the clinical trial logistics industries; siteless trials are trending, and we have worked tirelessly to provide first-rate direct-to-patient logistics services.
With a 10+ year track record in Direct-to-Patient, we have delivered over 7,000 DtP shipments to trial participants.
By meticulously designing these projects, we ensure our clients and their contractors are following the guidelines of GCP. Our team creates an individual logistics plan for each patient’s location to ensure smooth delivery and compliance.
Clinigen is carrier-neutral, and our Direct-to-Patient logistics pre-planning ensures your products are delivered at the right temperature and within the right guidelines.
Throughout each stage of the supply chain, our team ensures the privacy of patients, protecting patient health information.
>> For more information about how Clinigen’s Direct-to-Patient (DtP) platform is a patient-centric approach to the clinical supply shipping process, read our article titled The Rise of Direct-to-Patient.
When used in conjunction with On-Demand Packaging and Labelling, Clinigen is able to dispense daily dosing for a product that has a very short shelf life. These innovative services are truly setting the pathway for personalized medicine.
>> Read this Case Study to learn more about Clinigen’s Direct-to-Patient shipping services. The study explains how Clinigen was faced with an incredibly complicated study and took the time to create a solution that was not only effective but also revolutionary.
As a leading provider on a global scale, Clinigen is committed to delivering fully integrated logistics services to our clients. Over 80% of the studies we are supporting are multi-national and we organise shipments to 110+ countries.